Antifungal activity and mode of action of synthetic peptides derived from the tick OsDef2 defensin.

Candida albicans is the principal opportunistic fungal pathogen in nosocomial settings and resistance to antifungal drugs is on the rise. Antimicrobial peptides from natural sources are promising novel therapeutics against C. albicans.